Implementation of the 2018 Human Epidermal Growth Factor Receptor 2 Guideline by American Society of Clinical Oncology/College of American Pathologists Will Reduce False-Positive Tests

被引：4
|
作者：
Martin, Vittoria [1 ]
Valera, Alexandra [1 ]
De Joffrey, Melissa [1 ]
Banfi, Sara [1 ]
Mazzucchelli, Luca [1 ]
机构：
[1] Inst Pathol, Locarno, Switzerland
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2019年 / 143卷 / 04期
关键词：
IN-SITU HYBRIDIZATION; RECOMMENDATIONS;
D O I：
10.5858/arpa.2018-0904-LE
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：411 / 412
页数：2
相关论文
共 50 条
  • [31] National Guidelines and Level of Evidence: Comments on Some of the New Recommendations in the American Society of Clinical Oncology and the College of American Pathologists Human Epidermal Growth Factor Receptor 2 Guidelines for Breast Cancer Reply
    Wolff, Antonio C.
    Hammond, M. Elizabeth H.
    Hicks, David G.
    Allison, Kimberly H.
    Bartlett, John M. S.
    Bilous, Michael
    Fitzgibbons, Patrick
    Hanna, Wedad
    Jenkins, Robert B.
    Mangu, Pamela B.
    Paik, Soonmyung
    Perez, Edith A.
    Press, Michael F.
    Spears, Patricia A.
    Vance, Gail H.
    Viale, Giuseppe
    Dowsett, Mitch
    McShane, Lisa M.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11) : 1302 - 1304
  • [32] Interpretation of Human Epidermal Growth Factor Receptor 2 (HER2) In Situ Hybridization Assays Using 2013 Update of American Society of Clinical Oncology/College of American Pathologists HER2 Guidelines
    Bhargava, Rohit
    Dabbs, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) : 1855 - 1855
  • [33] Impact of the updated 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) gene testing in invasive breast cancers: A single center study
    Lim, Tse Hui
    Lim, Alvin Soon Tiong
    Tien, Sim Leng
    Tan, Puay Hoon
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 58
  • [34] Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio < 2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥ 6.0)
    Wilcock, Diane
    Sirohi, Deepika
    Albertson, Daniel
    Cleary, Allison S.
    Coleman, Joshua F.
    Jedrzkiewicz, Jolanta
    Mahlow, Jonathan
    Ruano, Ana L.
    Gulbahce, H. Evin
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (08) : 890 - 897
  • [35] Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? ASCO/College of American Pathologists Guidelines 2007, 2013, and 2018
    Murray, Ciara
    D'Arcy, Clare
    Gullo, Giuseppe
    Flanagan, Louise
    Quinn, Cecily M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (35) : 3522 - +
  • [36] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Goetz, Matthew P.
    Ingle, James N.
    Reynolds, Carol A.
    Perez, Edith A.
    Chen, Beiyun
    HUMAN PATHOLOGY, 2010, 41 (01) : 103 - 106
  • [37] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 testing in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Perez, Edith A.
    Chen, Beiyun
    VIRCHOWS ARCHIV, 2008, 452 : S23 - S24
  • [38] Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: a focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline
    Hoda, Raza S.
    Bowman, Anita S.
    Zehir, Ahmet
    Razavi, Pedram
    Brogi, Edi
    Ladanyi, Marc
    Arcila, Maria E.
    Wen, Hannah Y.
    Ross, Dara S.
    HISTOPATHOLOGY, 2021, 78 (04) : 498 - 507
  • [39] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Ventura, Christina B.
    Ismaila, Nofisat
    Colasacco, Carol
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (12) : 1345 - 1363
  • [40] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
    Bartley, Angela N.
    Washington, Mary Kay
    Colasacco, Carol
    Ventura, Christina B.
    Ismaila, Nofisat
    Benson, Al B., III
    Carrato, Alfredo
    Gulley, Margaret L.
    Jain, Dhanpat
    Kakar, Sanjay
    Mackay, Helen J.
    Streutker, Catherine
    Tang, Laura
    Troxell, Megan
    Ajani, Jaffer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 446 - +
12345